Showing results (861-870 of 1,041) with videos related to

Sort By:
Pageof 105
Environmental Research|November 27, 2020
Knowledge, attitudes, and practices on climate change and dengue in Lao People's Democratic Republic and ThailandMd Siddikur Rahman, Hans J Overgaard, Chamsai Pientong, et al.
Neurochemistry International|July 1, 2009
BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal culturesV Trajkovska, M A Santini, A B Marcussen, et al.
Journal of the American Academy of Dermatology|June 2, 2005
Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patientsSaskia A Bouwhuis, Mark D P Davis, Rokea A el-Azhary, et al.
Synapse (New York, N.Y.)|May 15, 2014
Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar ratsAnniek K D Visser, Peter Meerlo, Anders Ettrup, et al.
Neuroimage|November 7, 2022
Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effectsAnders S Olsen, Anders Lykkebo-Valløe, Brice Ozenne, et al.
Psychological Medicine|March 22, 2016
Neural correlates of improved executive function following erythropoietin treatment in mood disordersK W Miskowiak, M Vinberg, L Glerup, et al.
Elife|November 23, 2016
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repressionTrever T Greene, Maria Tokuyama, Giselle M Knudsen, et al.
Organic & Biomolecular Chemistry|May 6, 2017
18F-Labelling of electron rich iodonium ylides: application to the radiosynthesis of potential 5-HT2A receptor PET ligandsI N Petersen, J Villadsen, H D Hansen, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
Familial risk for major depression is associated with lower striatal 5-HT₄ receptor bindingKarine Madsen, Eva Torstensen, Klaus K Holst, et al.
Diabetes, Obesity & Metabolism|August 28, 2024
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trialThomas F Dejgaard, Christian S Frandsen, Urd Kielgast, et al.
Pageof 105